Ctr for Cardiovascular Innovation
Vancouver, British Columbia V5Z 1M9
0 studies enrolling now · 3 studies all time
What they study most
Heart Failure, Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Studies at this site
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
- A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis — Completed
- A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis — Running, not enrolling